|
Depomed Sues FDA, Alleges Agency Wrongfully Denied Orphan Drug Exclusivity
Depomed is taking the FDA to court, claiming the agency violated federal laws and its own regulations when it denied the company’s orphan drug Gralise seven years of marketing exclusivity.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives